20 series
Export
<<<Page of 1 >>>
Accession Title Series type(s) Organism(s) Samples GDS Supplementary Contact Release date
Remove filtersFilter Remove filterBW Remove filterHongjian Jin
GSE241645
PAX3-FOXO1 dictates myogenic reprogramming and rhabdomyosarcoma identity in endothelial progenitors [RNA-seq]
3 Hongjian Jin Sep 30, 2023
GSE207012
CUT&Tag of KDM4A, B and C in BE2C cells
6 Hongjian Jin Mar 04, 2024
GSE164454
KDM4 inhibition disrupts the core regulatory transcriptional circuitry in MYCN-driven neuroblastoma [Cut&Tag]
8 Hongjian Jin Mar 04, 2024
GSE198752
Targeting KDM4 for treating PAX3-FOXO1-driven alveolar rhabdomyosarcoma [ChIP-Seq, 2]
8 Hongjian Jin Sep 06, 2022
GSE198754
Targeting KDM4 for treating PAX3-FOXO1-driven alveolar rhabdomyosarcoma [CUT&Tag]
10 Hongjian Jin Sep 06, 2022
GSE151493
Identification of 17-DMAG as a novel KDM4B inhibitor for combination therapy [ChIP-seq]
12 Hongjian Jin Dec 22, 2020
GSE218265
PAX3-FOXO1 expression in endothelial progenitors dictates myogenic reprogramming and rhabdomyosarcoma identity[Cut&Run]
15 Hongjian Jin Sep 30, 2023
GSE157093
Targeting KDM4B to disrupt the core regulatory transcription network governed by PAX3-FOXO1 in high-risk rhabdomyosarcoma [CUT&RUN]
18 Hongjian Jin Sep 06, 2022
GSE198753
Targeting KDM4 for treating PAX3-FOXO1-driven alveolar rhabdomyosarcoma [CUT&RUN, 2]
18 Hongjian Jin Sep 06, 2022
GSE164451
KDM4 inhibition disrupts the core regulatory transcriptional circuitry in MYCN-driven neuroblastoma [ChIP-seq]
20 Hongjian Jin Mar 04, 2024
GSE151598
Identification of 17-DMAG as a novel KDM4B inhibitor for combination therapy
21 Hongjian Jin Dec 22, 2020
GSE157094
Targeting KDM4B to disrupt the core regulatory transcription network governed by PAX3-FOXO1 in high-risk rhabdomyosarcoma [ChIP-seq]
28 Hongjian Jin Sep 06, 2022
GSE207035
KDM4 histone lysine demethylases maintain the adrenergic core regulatory circuitry programed by MYCN in neuroblastoma
30 Hongjian Jin Mar 02, 2024
GSE108344
Spontaneous DIPG Modeling Reveals Novel H3.3 K27M-Mediated Oncogenic Mechanisms Acting Through Epigenetic Effects [ChIP-seq]
59 Hongjian Jin Jan 03, 2019
GSE164456
Histone lysine demethylase 4 family proteins maintain the transcriptional program and adrenergic cellular state of MYCN-amplified neuroblastoma
69 Hongjian Jin Mar 02, 2024
GSE218274
PAX3-FOXO1 expression in endothelial progenitors dictates myogenic reprogramming and rhabdomyosarcoma identity
75 Hongjian Jin Sep 29, 2023
GSE115872
H3.3 K27M depletion increases differentiation and extends latency of diffuse intrinsic pontine glioma growth in vivo [ChIP-Seq]
80 Hongjian Jin Mar 18, 2019
GSE108364
Spontaneous DIPG Modeling Reveals Novel H3.3 K27M-Mediated Oncogenic Mechanisms Acting Through Epigenetic Effects
100 Hongjian Jin Jan 03, 2019
GSE157095
Targeting KDM4B to disrupt the core regulatory transcription network governed by PAX3-FOXO1 in high-risk rhabdomyosarcoma
104 Hongjian Jin Sep 06, 2022
GSE115875
H3.3 K27M depletion increases differentiation and extends latency of diffuse intrinsic pontine glioma growth in vivo
130 Hongjian Jin Mar 18, 2019